BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lakatos PL. Recent trends in the epidemiology of inflammatory bowel diseases: Up or down? World J Gastroenterol 2006; 12(38): 6102-6108 [PMID: 17036379 DOI: 10.3748/wjg.v12.i38.6102]
URL: https://www.wjgnet.com/1007-9327/full/v12/i38/6102.htm
Number Citing Articles
1
Airi Jussila, Lauri J. Virta, Hannu Kautiainen, Matti Rekiaro, Urpo Nieminen, Martti A. Färkkilä. Increasing incidence of inflammatory bowel diseases between 2000 and 2007: A nationwide register study in FinlandInflammatory Bowel Diseases 2012; 18(3): 555 doi: 10.1002/ibd.21695
2
Xiaohan Cai, Yiding Liu, Xiang Zhou, Udayakumar Navaneethan, Bo Shen, Baochuan Guo. An LC-ESI-MS method for the quantitative analysis of bile acids composition in fecal materialsBiomedical Chromatography 2012; 26(1): 101 doi: 10.1002/bmc.1633
3
Zhao Cheng, Hong-ling Peng, Rong Zhang, Xian-ming Fu, Guang-sen Zhang. Bone marrow-derived innate macrophages attenuate oxazolone-induced colitisCellular Immunology 2017; 311: 46 doi: 10.1016/j.cellimm.2016.10.003
4
Lajos Sándor Kiss, Péter László Lakatos. Prediction of the disease course in inflammatory bowel diseasesOrvosi Hetilap 2010; 151(8): 293 doi: 10.1556/oh.2010.28813
5
Leonardo Corrêa de Oliveira Rodrigues, Magaly Gemio Teixeira, Roberta Thiery Godoy Arashiro, Desidério Roberto Kiss. Interação da gestação na atividade da doença inflamatória intestinal e sua influência sobre o prognóstico gestacional e na fecundidadeRevista Brasileira de Coloproctologia 2009; 29(3): 329 doi: 10.1590/S0101-98802009000300007
6
Ulrike Kuchler, Eloa R. Luvizuto, Fernando Muñoz, Julia Hofbauer, Georg Watzek, Reinhard Gruber. Bone healing around titanium implants in two rat colitis modelsClinical Oral Implants Research 2013; 24(2): 224 doi: 10.1111/j.1600-0501.2012.02454.x
7
Ho Yeol Cha, A Ram Jeong, Jin Hong Cheon, Sang Hyun Ahn, Sun Young Park, Ki Bong Kim. The Anti-oxidative and Anti-inflammatory Effect of Lonicera Japonica on Ulcerative Colitis Induced by Dextran Sulfate Sodium in MiceThe Journal of Korean Oriental Pediatrics 2015; 29(3): 54 doi: 10.7778/jpkm.2015.29.3.054
8
L. F. Azevedo, F. Magro, F. Portela, P. Lago, J. Deus, J. Cotter, I. Cremers, A. Vieira, P. Peixe, P. Caldeira, H. Lopes, R. Gonçalves, J. Reis, M. Cravo, L. Barros, P. Ministro, M. Lurdes, A. Duarte, M. Campos, L. Carvalho, A. Costa-Pereira. Estimating the prevalence of inflammatory bowel disease in Portugal using a pharmaco-epidemiological approachPharmacoepidemiology and Drug Safety 2010; 19(5): 499 doi: 10.1002/pds.1930
9
Yvette Meissner, Alf Lamprecht. Alternative Drug Delivery Approaches for the Therapy of Inflammatory Bowel DiseaseJournal of Pharmaceutical Sciences 2008; 97(8): 2878 doi: 10.1002/jps.21216
10
Petr Ricanek, Stephan Brackmann, Gøri Perminow, Lars G. Lyckander, Jon Sponheim, øyvind Holme, Ole Høie, Andreas Rydning, Morten H. Vatn. Evaluation of disease activity in IBD at the time of diagnosis by the use of clinical, biochemical, and fecal markersScandinavian Journal of Gastroenterology 2011; 46(9): 1081 doi: 10.3109/00365521.2011.584897
11
Hongchao Lv, Yongshuai Jiang, Jin Li, Mingming Zhang, Zhenwei Shang, Jiajia Zheng, Xin Wu, Panpan Liu, Ruijie Zhang, Huimin Yu. Association between polymorphisms in the promoter region of interleukin-10 and susceptibility to inflammatory bowel diseaseMolecular Biology Reports 2014; 41(3): 1299 doi: 10.1007/s11033-013-2975-7
12
Jerry L. Brunson, Felix Becker, Karen Y. Stokes. The impact of primary and persistent cytomegalovirus infection on the progression of acute colitis in a murine modelPathophysiology 2015; 22(1): 31 doi: 10.1016/j.pathophys.2014.11.001
13
Frank A. Wollheim. Kelley's Textbook of Rheumatology2009; : 1219 doi: 10.1016/B978-1-4160-3285-4.10073-7
14
Miquel Sans, Carolina Figueroa. Diagnostic Criteria in Autoimmune Diseases2008; : 329 doi: 10.1007/978-1-60327-285-8_61
15
Francisco Colina, Carolina Ibarrola, Javier Salamanca, Guadalupe López Alonso, Yolanda Rodríguez Gil. Guía para la interpretación de biopsias endoscópicas con sospecha de enfermedad inflamatoria intestinal idiopáticaRevista Española de Patología 2014; 47(3): 161 doi: 10.1016/j.patol.2014.03.001
16
Peter Laszlo Lakatos, Zsofia Czegledi, Gyula David, Zsofia Kispal, Lajos S Kiss, Karoly Palatka, Tunde Kristof, Ferenc Nagy, Agnes Salamon, Pal Demeter, Pal Miheller, Tamas Szamosi, Janos Banai, Maria Papp, Laszlo Bene, Agota Kovacs, Istvan Racz, Laszlo Lakatos. Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel diseaseJournal of Crohn's and Colitis 2010; 4(3): 283 doi: 10.1016/j.crohns.2009.11.011
17
Andrew Szilagyi, Xiaoqing Xue. Comparison of geographic distributions of Irritable Bowel Syndrome with Inflammatory Bowel Disease fail to support common evolutionary rootsMedical Hypotheses 2018; 110: 31 doi: 10.1016/j.mehy.2017.10.020
18
Laszlo Lakatos, Lajos S. Kiss, Gyula David, Tunde Pandur, Zsuzsanna Erdelyi, Gabor Mester, Mihaly Balogh, Istvan Szipocs, Csaba Molnar, Erzsebet Komaromi, Peter Laszlo Lakatos. Incidence, disease phenotype at diagnosis, and early disease course in inflammatory bowel diseases in Western Hungary, 2002–2006Inflammatory Bowel Diseases 2011; 17(12): 2558 doi: 10.1002/ibd.21607
19
Itishree Trivedi, Laurie Keefer. The Emerging Adult with Inflammatory Bowel Disease: Challenges and Recommendations for the Adult GastroenterologistGastroenterology Research and Practice 2015; 2015: 1 doi: 10.1155/2015/260807
20
Pedro Boal Carvalho, Francisca Dias de Castro, Bruno Rosa, Maria João Moreira, José Cotter. Mucosal Healing in Ulcerative Colitis – When Zero is BetterJournal of Crohn's and Colitis 2016; 10(1): 20 doi: 10.1093/ecco-jcc/jjv180
21
Ziad Kanaan, Shesh N. Rai, M. Robert Eichenberger, Christopher Barnes, Amy M. Dworkin, Clayton Weller, Eric Cohen, Henry Roberts, Bobby Keskey, Robert E. Petras, Nigel P.S. Crawford, Susan Galandiuk. Differential MicroRNA expression tracks neoplastic progression in inflammatory bowel disease-associated colorectal cancerHuman Mutation 2012; 33(3): 551 doi: 10.1002/humu.22021
22
F. Schmitz. Prädiktive Genetik bei chronisch-entzündlicher DarmerkrankungDer Gastroenterologe 2012; 7(1): 37 doi: 10.1007/s11377-011-0630-1
23
A. Stallmach, C. Langbein, R. Atreya, T. Bruns, A. Dignass, K. Ende, J. Hampe, F. Hartmann, M. F. Neurath, J. Maul, J. C. Preiss, R. Schmelz, B. Siegmund, H. Schulze, N. Teich, U. von Arnim, D. C. Baumgart, C. Schmidt. Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational studyAlimentary Pharmacology & Therapeutics 2016; 44(11-12): 1199 doi: 10.1111/apt.13813
24
Karin Malíčková, Dana Ďuricová, Martin Bortlík, Zdenka Hrušková, Barbora Svobodová, Naděžda Machková, Viktor Komárek, Terezie Fučíková, Ivana Janatková, Tomáš Zima, Milan Lukáš. Impaired Deoxyribonuclease I Activity in Patients with Inflammatory Bowel DiseasesAutoimmune Diseases 2011; 2011: 1 doi: 10.4061/2011/945861
25
William O. Cooper, T. Craig Cheetham, De-Kun Li, C. Michael Stein, S. Todd Callahan, Thomas M. Morgan, Ayumi K. Shintani, Ning Chen, Marie R. Griffin, Wayne A. Ray. Brief Report: Risk of Adverse Fetal Outcomes Associated With Immunosuppressive Medications for Chronic Immune-Mediated Diseases in PregnancyArthritis & Rheumatology 2014; 66(2): 444 doi: 10.1002/art.38262
26
Seyed Alireza Taghavi, Ali Reza Safarpour, Seyed Vahid Hosseini, Hesameddin Noroozi, Maral Safarpour, Sala Rahimikazerooni. Epidemiology of Inflammatory Bowel Diseases (IBD) in Iran: A Review of 740 Patients in Fars Province, Southern IranAnnals of Colorectal Research 2013; 1(1): 17 doi: 10.17795/acr-11477
27
Peter L. Lakatos, Barbara D. Lovasz, Gyula David, Tunde Pandur, Zsuzsanna Erdelyi, Gabor Mester, Mihaly Balogh, Istvan Szipocs, Csaba Molnar, Erzsebet Komaromi, Petra A. Golovics, Zsuzsanna Vegh, Michael Mandel, Agnes Horvath, Miklos Szathmari, Lajos S. Kiss, Laszlo Lakatos. The risk of lymphoma and immunomodulators in patients with inflammatory bowel diseases: Results from a population-based cohort in Eastern EuropeJournal of Crohn's and Colitis 2013; 7(5): 385 doi: 10.1016/j.crohns.2012.06.011
28
Hang Zhu, Xun Lei, Qin Liu, Yang Wang. Interleukin-10-1082A/G polymorphism and inflammatory bowel disease susceptibility: A meta-analysis based on 17,585 subjectsCytokine 2013; 61(1): 146 doi: 10.1016/j.cyto.2012.09.009
29
Raquel F. Leal, Francesca A. Ramos Silva. Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging2017; : 313 doi: 10.1016/B978-0-12-812146-7.00014-7
30
Intestinal tuberculosis and schistosomiasis presenting like Crohn's diseaseInternal Medicine Journal 2009; 39(12): e13 doi: 10.1111/j.1445-5994.2009.02099.x
31
Ibrahim Zvidi, Rachel Hazazi, Shlomo Birkenfeld, Yaron Niv. The Prevalence of Crohn’s Disease in Israel: A 20-Year SurveyDigestive Diseases and Sciences 2009; 54(4): 848 doi: 10.1007/s10620-008-0429-1
32
Amosy E. M'koma. Inflammatory Bowel Disease: An Expanding Global Health ProblemClinical Medicine Insights: Gastroenterology 2013; 6: CGast.S12731 doi: 10.4137/CGast.S12731
33
Siu Wai Tsang, Siu Po Ip, Justin Che-Yuen Wu, Siew-Chien Ng, Ken Kin-Lam Yung, Zhao-Xiang Bian. A Chinese medicinal formulation ameliorates dextran sulfate sodium-induced experimental colitis by suppressing the activity of nuclear factor-kappaB signalingJournal of Ethnopharmacology 2015; 162: 20 doi: 10.1016/j.jep.2014.12.035
34
Zhong-Kai Lu, Zhi-Rong Chen, Jun-Yi Zhu, Ya Xu, Xian Hua. Analysis of the association of single nucleotide polymorphisms of interleukin-23 receptor (IL-23R) and inflammatory bowel disease in a Chinese Han cohortOncotarget 2016; 7(42): 67851 doi: 10.18632/oncotarget.12296
35
Bente Mertz Nørgård, Jan Nielsen, Kirsten Fonager, Jens Kjeldsen, Bent Ascanius Jacobsen, Niels Qvist. The incidence of ulcerative colitis (1995–2011) and Crohn's disease (1995–2012) — Based on nationwide Danish registry dataJournal of Crohn's and Colitis 2014; 8(10): 1274 doi: 10.1016/j.crohns.2014.03.006
36
Jun-yong Choi, Sang-hyun Ahn, Yin-hao Shih, Bok-suk Sa, Ki-bong Kim. Mitigating Effect of Jageum-jung on Dextran Sulfate Sodium-induced Ulcerative Colitis through Anti-inflammatory RegulationThe Journal of Internal Korean Medicine 2017; 38(6): 944 doi: 10.22246/jikm.2017.38.6.944
37
Elisabet Cantó, Carlos Zamora, Esther Garcia-Planella, Jordi Gordillo, M Angels Ortiz, Lidia Perea, Silvia Vidal. Bacteria-related Events and the Immunological Response of Onset and Relapse Adult Crohn’s Disease PatientsJournal of Crohn's and Colitis 2019; 13(1): 92 doi: 10.1093/ecco-jcc/jjy138
38
Bamidele Johnson Alegbeleye. Crohn’s disease in a developing African mission hospital: a case reportJournal of Medical Case Reports 2019; 13(1) doi: 10.1186/s13256-019-1971-5
39
Szilard Poliska, Andras Penyige, Peter Laszlo Lakatos, Maria Papp, Karoly Palatka, Laszlo Lakatos, Tamas Molnar, Laszlo Nagy. Association of peroxisome proliferator-activated receptor gamma polymorphisms with inflammatory bowel disease in a Hungarian cohortInflammatory Bowel Diseases 2012; 18(3): 472 doi: 10.1002/ibd.21798
40
S. Givvimani, C. Munjal, N. Narayanan, F. Aqil, G. Tyagi, N. Metreveli, S. C. Tyagi. Hyperhomocysteinemia decreases intestinal motility leading to constipationAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2012; 303(3): G281 doi: 10.1152/ajpgi.00423.2011
41
Yuan Gao, Yujie Huang, Yue Zhao, Yang Hu, Zhiyu Li, Qinglong Guo, Kai Zhao, Na Lu. LL202 protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting MAPK/AP-1 signalingOncotarget 2016; 7(39): 63981 doi: 10.18632/oncotarget.11742
42
Phani Krishna Kondamudi, Rajkumar Malayandi, Chandramohan Eaga, Deepika Aggarwal. Drugs as causative agents and therapeutic agents in inflammatory bowel diseaseActa Pharmaceutica Sinica B 2013; 3(5): 289 doi: 10.1016/j.apsb.2013.06.004
43
Ignacio Catalan-Serra, Arne Kristian Sandvik, Torunn Bruland, Juan Carlos Andreu-Ballester. Gammadelta T Cells in Crohn’s Disease: A New Player in the Disease Pathogenesis?Journal of Crohn's and Colitis 2017; 11(9): 1135 doi: 10.1093/ecco-jcc/jjx039
44
Eiichi Momotani, Hiroshi Ozaki, Masatoshi Hori, Shizuo Yamamoto, Takashi Kuribayashi, Shigetoshi Eda, Masahiro Ikegami. Mycobacterium avium subsp. paratuberculosis lipophilic antigen causes Crohn’s disease-type necrotizing colitis in MiceSpringerPlus 2012; 1(1) doi: 10.1186/2193-1801-1-47
45
Scott R. Kelley, Eric J. Dozois. Colorectal Surgery2014; : 119 doi: 10.1016/B978-0-7020-4965-1.00009-3
46
Thomas Clavel, Dirk Haller. Bacteria- and host-derived mechanisms to control intestinal epithelial cell homeostasis: Implications for chronic inflammationInflammatory Bowel Diseases 2007; 13(9): 1153 doi: 10.1002/ibd.20174
47
Pegah Hosseini-Carroll, Monica Mutyala, Abhishek Seth, Shaheen Nageeb, Demiana Soliman, Moheb Boktor, Ankur Sheth, Jonathon Chapman, James Morris, Paul Jordan, Kenneth Manas, Felix Becker, Jonathan Steven Alexander. Pregnancy and inflammatory bowel diseases: Current perspectives, risks and patient managementWorld Journal of Gastrointestinal Pharmacology and Therapeutics 2015; 6(4): 156-171 doi: 10.4292/wjgpt.v6.i4.156
48
Nick Kalogeropoulos, Antonia Chiou, Andriana C. Kaliora, Vaios T. Karathanos, Nikolaos K. Andrikopoulos. Emerging Trends in Dietary Components for Preventing and Combating DiseaseACS Symposium Series 2012; 1093: 237 doi: 10.1021/bk-2012-1093.ch013
49
Agnieszka Kokoszko-Bilska, Slawomir Sobkiewicz, Jakub Fichna. Inflammatory bowel diseases and reproductive healthPharmacological Reports 2016; 68(4): 859 doi: 10.1016/j.pharep.2016.03.009
50
M Oliva-Hemker, JC Escher, D Moore, M Dubinksy, H Hildebrand, YKL Koda, S Murch, B Sandhu, JK Seo, MN Tanzi, B Warner. Refractory Inflammatory Bowel Disease in ChildrenJournal of Pediatric Gastroenterology & Nutrition 2008; 47(2): 266 doi: 10.1097/MPG.0b013e318181b48c
51
Prosenjit Saha, Palanikumar Manoharan, Subha Arthur, Shanmuga Sundaram, Ramesh Kekuda, Uma Sundaram. Molecular mechanism of regulation of villus cell Na-K-ATPase in the chronically inflamed mammalian small intestineBiochimica et Biophysica Acta (BBA) - Biomembranes 2015; 1848(2): 702 doi: 10.1016/j.bbamem.2014.11.005
52
Ohad Atia, Adi Shosberger, Gili Focht, Oren Ledder, Raffi Lev-Tzion, Dan Navon, Amit Assa, Baruch Yerushalmi, Ron Shaoul, Dror S Shouval, Ariella Bar-Gil Shitrit, Benjamin Koslowsky, Iris Dotan, Revital Kariv, Eitan Lavon, Dan Turner. Development and Validation of the IBD-REFER Criteria: Early Referral for Suspected Inflammatory Bowel Diseases in Adults and ChildrenCrohn's & Colitis 360 2020; 2(2) doi: 10.1093/crocol/otaa027
53
Outpatient Nutrition Care and Home Nutrition Support2016; : 43 doi: 10.1201/9781315381664-5
54
Jean Lachaine, Linnette Yen, Catherine Beauchemin, Paul Hodgkins. Medication adherence and persistence in the treatment of Canadian ulcerative colitis patients: analyses with the RAMQ databaseBMC Gastroenterology 2013; 13(1) doi: 10.1186/1471-230X-13-23
55
Béatrice Romier, Jacqueline Van De Walle, Alexandrine During, Yvan Larondelle, Yves-Jacques Schneider. Modulation of signalling nuclear factor-κB activation pathway by polyphenols in human intestinal Caco-2 cellsBritish Journal of Nutrition 2008; 100(03): 542 doi: 10.1017/S0007114508966666
56
Barbara D. Lovasz, Petra A. Golovics, Zsuzsanna Vegh, Peter L. Lakatos. New trends in inflammatory bowel disease epidemiology and disease course in Eastern EuropeDigestive and Liver Disease 2013; 45(4): 269 doi: 10.1016/j.dld.2012.08.020
57
Dorottya Kocsis, Zsuzsanna Tóth, Ágnes A. Csontos, Pál Miheller, Péter Pák, László Herszényi, Miklós Tóth, Zsolt Tulassay, Márk Juhász. Prevalence of inflammatory bowel disease among coeliac disease patients in a Hungarian coeliac centreBMC Gastroenterology 2015; 15(1) doi: 10.1186/s12876-015-0370-7
58
Tamas Szamosi, Janos Banai, Laszlo Lakatos, Zsofia Czegledi, Gyula David, Ferenc Zsigmond, Tunde Pandur, Zsuzsanna Erdelyi, Orsolya Gemela, Maria Papp, Janos Papp, Peter Laszlo Lakatos. Early azathioprine/biological therapy is associated with decreased risk for first surgery and delays time to surgery but not reoperation in both smokers and nonsmokers with Crohnʼs disease, while smoking decreases the risk of colectomy in ulcerative colitisEuropean Journal of Gastroenterology & Hepatology 2010; 22(7): 872 doi: 10.1097/MEG.0b013e32833036d9
59
ParthaPratim Pal, MadhuSudhan Ghosh, Abhijit Chakma. Homoeopathic treatment of ulcerative Colitis: A case reportIndian Journal of Research in Homoeopathy 2017; 11(1): 74 doi: 10.4103/0974-7168.200842
60
Michel Underner, Jean Perriot, Jacques Cosnes, Philippe Beau, Gérard Peiffer, Jean-Claude Meurice. Tabagisme, sevrage tabagique et maladie de CrohnLa Presse Médicale 2016; 45(4): 390 doi: 10.1016/j.lpm.2016.02.008
61
Amrollah Sharifi, Homayoon Vahedi, Saharnaz Nedjat, Hossein Rafiei, Mohammad Javad Hosseinzadeh‐Attar. Effect of single‐dose injection of vitamin D on immune cytokines in ulcerative colitis patients: a randomized placebo‐controlled trialAPMIS 2019; 127(10): 681 doi: 10.1111/apm.12982
62
Rossana Colla Soletti, Nathassya Accioly Lins Vidal Rodrigues, Deborah Biasoli, Ronir Raggio Luiz, Heitor Siffert Pereira de Souza, Helena Lobo Borges, Anthony WI. Lo. Immunohistochemical Analysis of Retinoblastoma and β-Catenin as an Assistant Tool in the Differential Diagnosis between Crohn's Disease and Ulcerative ColitisPLoS ONE 2013; 8(8): e70786 doi: 10.1371/journal.pone.0070786
63
Yue Tan, Yadi Guan, Yan Sun, Changqing Zheng. Correlation of Intestinal Mucosal Healing and Tight Junction Protein Expression in Ulcerative Colitis PatientsThe American Journal of the Medical Sciences 2019; 357(3): 195 doi: 10.1016/j.amjms.2018.11.011
64
Dirk Haller, Jean-Michel Antoine, Stig Bengmark, Paul Enck, Ger T. Rijkers, Irene Lenoir-Wijnkoop. Guidance for Substantiating the Evidence for Beneficial Effects of Probiotics: Probiotics in Chronic Inflammatory Bowel Disease and the Functional Disorder Irritable Bowel SyndromeThe Journal of Nutrition 2010; 140(3): 690S doi: 10.3945/jn.109.113746
65
Yu Chen, Earl G. Noble. Is exercise beneficial to the inflammatory bowel diseases? An implication of heat shock proteinsMedical Hypotheses 2009; 72(1): 84 doi: 10.1016/j.mehy.2008.06.045
66
Benoît Dupont, Claire Dupont, Anne-Marie Justum, Marie-Astrid Piquet, Jean-Marie Reimund. Enteral nutrition in adult Crohn's disease: Present status and perspectivesMolecular Nutrition & Food Research 2008; 52(8): 875 doi: 10.1002/mnfr.200800093
67
Prabhakar P. Swaroop. Inflammatory Bowel Diseases in the ElderlyClinics in Geriatric Medicine 2007; 23(4): 809 doi: 10.1016/j.cger.2007.06.007
68
Pamela R. Puthoor, Edwin F. de Zoeten. Pediatric Ulcerative Colitis: The Therapeutic Road to InfliximabBiologics in Therapy 2013; 3(1): 1 doi: 10.1007/s13554-012-0006-1
69
Seung Joo Kang, Jung Mogg Kim, Seong-Joon Koh, Su Hyun Kim, Jong Pil Im, Hyun Chae Jung, Joo Sung Kim. The guggulsterone derivative GG-52 inhibits NF-κB signaling in bone marrow-derived dendritic cells and attenuates colitis in IL-10 knockout miceLife Sciences 2013; 92(22): 1064 doi: 10.1016/j.lfs.2013.04.003
70
Dahae Lim, Youngwoo Cho, Woogyeong Kim, Sehee Jeong, Young Pyo Jang, Jinju Kim. Original Research: Extract of Bambusae Caulis in Taeniam inhibits cigarette smoke-induced pulmonary and intestinal inflammationExperimental Biology and Medicine 2017; 242(1): 102 doi: 10.1177/1535370216664429
71
J. Goodhand, C.R. Hedin, N.M. Croft, J.O. Lindsay. Adolescents with IBD: The importance of structured transition careJournal of Crohn's and Colitis 2011; 5(6): 509 doi: 10.1016/j.crohns.2011.03.015
72
Stephanie N. Lewis, Zulma Garcia, Raquel Hontecillas, Josep Bassaganya-Riera, David R. Bevan. Pharmacophore modeling improves virtual screening for novel peroxisome proliferator-activated receptor-gamma ligandsJournal of Computer-Aided Molecular Design 2015; 29(5): 421 doi: 10.1007/s10822-015-9831-x
73
Si Ming Man, Li Zhang, Andrew S. Day, Steven Leach, Hazel Mitchell. Detection of Enterohepatic and GastricHelicobacterSpecies in Fecal Specimens of Children with Crohn's DiseaseHelicobacter 2008; 13(4): 234 doi: 10.1111/j.1523-5378.2008.00607.x
74
Daniela Rogler, Nicolas Fournier, Valérie Pittet, Patrick Bühr, Klaas Heyland, Michael Friedt, Rebekka Koller, Vanessa Rueger, Denise Herzog, Andreas Nydegger, Michela Schäppi, Susanne Schibli, Johannes Spalinger, Gerhard Rogler, Christian P. Braegger. Coping is excellent in Swiss Children with inflammatory bowel disease: Results from the Swiss IBD cohort studyJournal of Crohn's and Colitis 2014; 8(5): 409 doi: 10.1016/j.crohns.2013.10.004
75
Hong Yang, Yumei Li, Wei Wu, Qingwen Sun, Yunzhong Zhang, Wei Zhao, Hongbo Lv, Qing Xia, Pinjin Hu, Haihua Li, Jiaming Qian, Xiaoping Miao. The Incidence of Inflammatory Bowel Disease in Northern China: A Prospective Population-Based StudyPLoS ONE 2014; 9(7): e101296 doi: 10.1371/journal.pone.0101296
76
Jermain Kaminski. Boundaryless Hospital2016; : 295 doi: 10.1007/978-3-662-49012-9_17
77
Yan-Feng Huang, Jiang-Tao Zhou, Chang Qu, Yao-Xing Dou, Qiong-Hui Huang, Zhi-Xiu Lin, Yan-Fang Xian, Jian-Hui Xie, You-Liang Xie, Xiao-Ping Lai, Zi-Ren Su. Anti-inflammatory effects of Brucea javanica oil emulsion by suppressing NF-κB activation on dextran sulfate sodium-induced ulcerative colitis in miceJournal of Ethnopharmacology 2017; 198: 389 doi: 10.1016/j.jep.2017.01.042
78
Jennifer L. Barnes, Kelly A. Tappenden. Nutrition in the Prevention and Treatment of Disease2013; : 739 doi: 10.1016/B978-0-12-391884-0.00039-1
79
Monika Schneider. Mouse Models of Innate ImmunityMethods in Molecular Biology 2013; 1031: 189 doi: 10.1007/978-1-62703-481-4_21
80
Chen-Wang Chang, Chia-Hung Tu, Jen-Wei Chou, Tien-Yu Huang, Wen-Hung Hsu, Yen-Po Wang, Chih-Cheng Chen, Chen-Shuan Chung, Ching-Pin Lin, Wei-Chen Lin, Chi-Ming Tai, Horng-Yuan Wang, Ming-Jen Chen. Endoscopic management of strictures in patients with Crohn's disease - A multi-center experience in TaiwanJournal of the Formosan Medical Association 2020; 119(10): 1500 doi: 10.1016/j.jfma.2019.12.005
81
B. Vucelic, S. Cukovic-Cavka. IBD 2007 — Achievements in Research and Clinical PracticeFalk Symposium 2008; 159: 30 doi: 10.1007/978-1-4020-6987-1_3
82
Sek Won Kong, In-Hee Lee, Ignaty Leshchiner, Joel Krier, Peter Kraft, Heidi L. Rehm, Robert C. Green, Isaac S. Kohane, Calum A. MacRae. Summarizing polygenic risks for complex diseases in a clinical whole-genome reportGenetics in Medicine 2015; 17(7): 536 doi: 10.1038/gim.2014.143
83
Esther A. Torres, Abdiel Cruz, Mariola Monagas, Marina Bernal, Yadira Correa, Rafael Cordero, Víctor L. Carlo. Inflammatory Bowel Disease in Hispanics: The University of Puerto Rico IBD RegistryInternational Journal of Inflammation 2012; 2012: 1 doi: 10.1155/2012/574079
84
Daniel G. Fernández-Ávila, Santiago Bernal-Macías, Viviana Parra-Izquierdo, Diana N. Rincón-Riaño, Juan M. Gutiérrez, Diego Rosselli. Prevalence of inflammatory bowel disease and related arthritis in Colombia, according to information from the Health and Social Protection Data SystemRevista Colombiana de Reumatología (English Edition) 2020; 27(1): 3 doi: 10.1016/j.rcreue.2019.10.005
85
Moftah H. Alhagamhmad, Andrew S. Day, Daniel A. Lemberg, Steven T. Leach. An update of the role of nutritional therapy in the management of Crohn’s diseaseJournal of Gastroenterology 2012; 47(8): 872 doi: 10.1007/s00535-012-0617-9
86
Ming Yue Li, Zhi Hong Zhang, Zhe Wang, Hong Xiang Zuo, Jing Ying Wang, Yue Xing, Cheng Hua Jin, Guang Hua Xu, Lian Xun Piao, Juan Ma, Xuejun Jin. Convallatoxin protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB signaling through activation of PPARγPharmacological Research 2019; 147: 104355 doi: 10.1016/j.phrs.2019.104355
87
Van de star Tamara. "Role of Psychosocial Factors on the Course of Inflammatory Bowel Disease and Associated Psychotherapeutic Approaches. A Fresh Perspective and Review"Gastroenterology & Hepatology : Open Access 2015; 2(2) doi: 10.15406/ghoa.2015.02.00038
88
Henusha D. Jhundoo, Tobias Siefen, Alfred Liang, Christoph Schmidt, John Lokhnauth, Arnaud Béduneau, Yann Pellequer, Crilles Casper Larsen, Alf Lamprecht. Anti-Inflammatory Activity of Chitosan and 5-Amino Salicylic Acid Combinations in Experimental ColitisPharmaceutics 2020; 12(11): 1038 doi: 10.3390/pharmaceutics12111038
89
Hamid Reza Sodagari, Mohammad Hosein Farzaei, Roodabeh Bahramsoltani, Amir Hossein Abdolghaffari, Maryam Mahmoudi, Nima Rezaei. Dietary anthocyanins as a complementary medicinal approach for management of inflammatory bowel diseaseExpert Review of Gastroenterology & Hepatology 2015; 9(6): 807 doi: 10.1586/17474124.2015.1002086
90
Mariyana Schoultz, Leah Macaden, Angus J. M. Watson. Co-designing inflammatory bowel disease (Ibd) services in Scotland: findings from a nationwide surveyBMC Health Services Research 2016; 16(1) doi: 10.1186/s12913-016-1490-7
91
Jeff Huaqing Ye, Vazhaikkurichi M Rajendran. Adenosine: An immune modulator of inflammatory bowel diseasesWorld Journal of Gastroenterology 2009; 15(36): 4491-4498 doi: 10.3748/wjg.15.4491
92
Béatrice Romier, Yves-Jacques Schneider, Yvan Larondelle, Alexandrine During. Dietary polyphenols can modulate the intestinal inflammatory responseNutrition Reviews 2009; 67(7): 363 doi: 10.1111/j.1753-4887.2009.00210.x
93
Paz Valer, Alicia Algaba, Daniel Santos, Manuel E. Fuentes, Elva Nieto, Javier P. Gisbert, Pilar López, Elvira Quintanilla, Francisco J. García-Alonso, Iván Guerra, Álvaro Páez, Fernando Bermejo. Evaluation of the Quality of Semen and Sexual Function in Men with Inflammatory Bowel DiseaseInflammatory Bowel Diseases 2017; 23(7): 1144 doi: 10.1097/MIB.0000000000001081
94
Sonal Varma, Ranjana Bird, Michael Eskin, Brion Dolenko, Jayadev Raju, Tedros Bezabeh. Detection of inflammatory bowel disease by proton magnetic resonance spectroscopy (1H MRS) using an animal modelJournal of Inflammation 2007; 4(1) doi: 10.1186/1476-9255-4-24
95
Yuan Gao, Dongsheng Bai, Yue Zhao, Qin Zhu, Yihui Zhou, Zhiyu Li, Na Lu. LL202 ameliorates colitis against oxidative stress of macrophage by activation of the Nrf2/HO‐1 pathwayJournal of Cellular Physiology 2019; 234(7): 10625 doi: 10.1002/jcp.27739
96
Frank A. Wollheim, Monika Ronneberger. Kelley's Textbook of Rheumatology2013; : 1251 doi: 10.1016/B978-1-4377-1738-9.00078-5
97
Maiko Tatsuki, Reiko Hatori, Tomoko Nakazawa, Takashi Ishige, Tomoko Hara, Seiichi Kagimoto, Takeshi Tomomasa, Hirokazu Arakawa, Takumi Takizawa. Serological cytokine signature in paediatric patients with inflammatory bowel disease impacts diagnosisScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-71503-y
98
Peter Laszlo Lakatos, Lajos Sandor Kiss, Karoly Palatka, Istvan Altorjay, Peter Antal-Szalmas, Eszter Palyu, Miklos Udvardy, Tamas Molnar, Klaudia Farkas, Gabor Veres, Jolan Harsfalvi, Janos Papp, Maria Papp. Serum lipopolysaccharide-binding protein and soluble CD14 are markers of disease activity in patients with Crohnʼs diseaseInflammatory Bowel Diseases 2011; 17(3): 767 doi: 10.1002/ibd.21402
99
Steffen Wohlgemuth, Dirk Haller, Michael Blaut, Gunnar Loh. Reduced microbial diversity and high numbers of one singleEscherichia colistrain in the intestine of colitic miceEnvironmental Microbiology 2009; 11(6): 1562 doi: 10.1111/j.1462-2920.2009.01883.x
100
Hu Jianzhong. The Genetic Predisposition and the Interplay of Host Genetics and Gut Microbiome in Crohn DiseaseClinics in Laboratory Medicine 2014; 34(4): 763 doi: 10.1016/j.cll.2014.08.003
101
Rowann Bowcutt, Lisa B. Malter, Lea Ann Chen, Martin J. Wolff, Ian Robertson, Daniel B. Rifkin, Michael Poles, Ilseug Cho, P'ng Loke. Isolation and cytokine analysis of lamina propria lymphocytes from mucosal biopsies of the human colonJournal of Immunological Methods 2015; 421: 27 doi: 10.1016/j.jim.2015.02.012
102
D. Christophorou, N. Funakoshi, Y. Duny, J.-C. Valats, M. Bismuth, G. Pineton De Chambrun, J.-P. Daures, P. Blanc. Systematic review with meta-analysis: infliximab and immunosuppressant therapy vs. infliximab alone for active ulcerative colitisAlimentary Pharmacology & Therapeutics 2015; 41(7): 603 doi: 10.1111/apt.13102
103
Valentina Colonnello, Alessandro Agostini. Disease course, stress, attachment, and mentalization in patients with inflammatory bowel diseaseMedical Hypotheses 2020; 140: 109665 doi: 10.1016/j.mehy.2020.109665
104
Surinder Singh Rana, Vishal Sharma, Ravi Sharma, Ritambhra Nada, Rajesh Gupta, Deepak Kumar Bhasin. Capsule endoscopy in small bowel Crohn’s disease and TuberculosisTropical Doctor 2017; 47(2): 113 doi: 10.1177/0049475516686542
105
Nancy M. Benight, Barbara Stoll, Juan C. Marini, Douglas G. Burrin. Preventative oral methylthioadenosine is anti-inflammatory and reduces DSS-induced colitis in miceAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2012; 303(1): G71 doi: 10.1152/ajpgi.00549.2011
106
Isabel Andújar, José Luis Ríos, Rosa María Giner, José Miguel Cerdá, María del Carmen Recio. Beneficial Effect of Shikonin on Experimental Colitis Induced by Dextran Sulfate Sodium in Balb/C MiceEvidence-Based Complementary and Alternative Medicine 2012; 2012: 1 doi: 10.1155/2012/271606
107
JOEL K. GREENSON, ROBERT D. ODZE. Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas2009; : 355 doi: 10.1016/B978-141604059-0.50017-5
108
Zunwu Zhang, Hugh Kennedy. Ulcerative colitis: current medical therapy and strategies for improving medication adherenceEuropean Journal of Gastroenterology & Hepatology 2009; 21(1): 1 doi: 10.1097/MEG.0b013e32830bfb88
109
Daniel Sjöberg, Tommy Holmström, Märit Larsson, Anne-Lie Nielsen, Lars Holmquist, Anders Ekbom, Anders Rönnblom. Incidence and natural history of ulcerative colitis in the Uppsala Region of Sweden 2005–2009 — Results from the IBD Cohort of the Uppsala Region (ICURE)Journal of Crohn's and Colitis 2013; 7(9): e351 doi: 10.1016/j.crohns.2013.02.006
110
Chang Hwan Choi, Young-Ho Kim, You Sun Kim, Byong Duk Ye, Kang Moon Lee, Bo In Lee, Sung-Ae Jung, Won Ho Kim, Heeyoung Lee. Guidelines for the Management of Ulcerative ColitisThe Korean Journal of Gastroenterology 2012; 59(2): 118 doi: 10.4166/kjg.2012.59.2.118
111
Nathalie E. Ruyssers, Benedicte Y. De Winter, Joris G. De Man, Alex Loukas, Arnold G. Herman, Paul A. Pelckmans, Tom G. Moreels. Worms and the Treatment of Inflammatory Bowel Disease: Are Molecules the Answer?Clinical and Developmental Immunology 2008; 2008: 1 doi: 10.1155/2008/567314
112
Yi-Fang Chen, Jin-Juan Zheng, Chao Qu, Yao Xiao, Fang-Fang Li, Quan-Xin Jin, Hong-Hua Li, Fan-Ping Meng, Gui-Hua Jin, Dan Jin. Inonotus obliquus polysaccharide ameliorates dextran sulphate sodium induced colitis involving modulation of Th1/Th2 and Th17/Treg balanceArtificial Cells, Nanomedicine, and Biotechnology 2019; 47(1): 757 doi: 10.1080/21691401.2019.1577877
113
Angélica Cruz-Lebrón, Leticia D’argenio Garcia, Aarthi Talla, Samira Joussef-Piña, Miguel E Quiñones-Mateu, Rafick-Pierre Sékaly, Karina Inacio Ladislau de Carvalho, Alan D Levine. Decreased Enteric Bacterial Composition and Diversity in South American Crohn’s Disease Vary With the Choice of Treatment Strategy and Time Since DiagnosisJournal of Crohn's and Colitis 2020; 14(6): 791 doi: 10.1093/ecco-jcc/jjz189
114
Niharika Mehta, Sumona Saha, Edward K. S. Chien, Silvia Degli Esposti, Scott Segal. de Swiet's Medical Disorders in Obstetric Practice2010; : 256 doi: 10.1002/9781444323016.ch10
115
Serena Barello, Elena Guida, Salvatore Leone, Enrica Previtali, Guendalina Graffigna. Does patient engagement affect IBD patients’ health-related quality of life? Findings from a cross-sectional study among people with inflammatory bowel diseasesHealth and Quality of Life Outcomes 2021; 19(1) doi: 10.1186/s12955-021-01724-w
116
Siew C Ng. Changing Epidemiology and Future Challenges of Inflammatory Bowel Disease in AsiaIntestinal Research 2010; 8(1): 1 doi: 10.5217/ir.2010.8.1.1
117
Ivana Kern, Olaf Schoffer, Wieland Kiess, Jobst Henker, Martin W. Laaß, Ulf Winkler, Jürgen Quietzsch, Olaf Wenzel, Marlen Zurek, Katrin Büttner, Peter Fischer, Jan de Laffolie, Ulf Manuwald, Thoralf Stange, Ronny Zenker, Jens Weidner, Klaus-Peter Zimmer, Hildebrand Kunath, Joachim Kugler, Thomas Richter, Ulrike Rothe, Valérie Pittet. Incidence trends of pediatric onset inflammatory bowel disease in the years 2000–2009 in Saxony, Germany–first results of the Saxon Pediatric IBD RegistryPLOS ONE 2021; 16(1): e0243774 doi: 10.1371/journal.pone.0243774
118
A. Jay Freeman, Tatyana Hofmekler, John-Paul Berauer, Sirish Palle. Update in Pediatrics2018; : 267 doi: 10.1007/978-3-319-58027-2_10
119
Jan Seibel, Almut F. Molzberger, Torsten Hertrampf, Ute Laudenbach-Leschowski, Gisela H. Degen, Patrick Diel. In utero and postnatal exposure to a phytoestrogen-enriched diet increases parameters of acute inflammation in a rat model of TNBS-induced colitisArchives of Toxicology 2008; 82(12): 941 doi: 10.1007/s00204-008-0309-7
120
Young Jin Lee, Eui Geum Oh. Body Image, Self Esteem, and Health related Quality of Life in Patients with Crohn's DiseaseKorean Journal of Adult Nursing 2014; 26(4): 383 doi: 10.7475/kjan.2014.26.4.383
121
Peter Laszlo Lakatos, Gyula David, Tunde Pandur, Zsuzsanna Erdelyi, Gabor Mester, Mihaly Balogh, Istvan Szipocs, Csaba Molnar, Erzsebet Komaromi, Lajos S. Kiss, Laszlo Lakatos. IBD in the elderly population: Results from a population-based study in Western Hungary, 1977–2008Journal of Crohn's and Colitis 2011; 5(1): 5 doi: 10.1016/j.crohns.2010.08.004
122
Kurexi Yunusi, Jingping Zhang, Li Zhong, Gulinisha Mosha, Ajiguli Nuermaimaiti, Mairipaiti Abudula, Halmurat Upur. Uygur Medicine Xipayi Kui Jie’an Affects Gene Expression profiles in intestinal tissue Lesions in a Rat Model of Ulcerative ColitisBMC Complementary and Alternative Medicine 2015; 15(1) doi: 10.1186/s12906-015-0672-x
123
Siew C. Ng. Epidemiology of inflammatory bowel disease: Focus on AsiaBest Practice & Research Clinical Gastroenterology 2014; 28(3): 363 doi: 10.1016/j.bpg.2014.04.003
124
Yun Chen, Ming Zhang, Fazheng Ren. A Role of Exopolysaccharide Produced by Streptococcus thermophilus in the Intestinal Inflammation and Mucosal Barrier in Caco-2 Monolayer and Dextran Sulphate Sodium-Induced Experimental Murine ColitisMolecules 2019; 24(3): 513 doi: 10.3390/molecules24030513
125
Heiner Boeing, Angela Bechthold, Achim Bub, Sabine Ellinger, Dirk Haller, Anja Kroke, Eva Leschik-Bonnet, Manfred J. Müller, Helmut Oberritter, Matthias Schulze, Peter Stehle, Bernhard Watzl. Critical review: vegetables and fruit in the prevention of chronic diseasesEuropean Journal of Nutrition 2012; 51(6): 637 doi: 10.1007/s00394-012-0380-y
126
Anita Afzali, Raymond K. Cross. Racial and Ethnic Minorities with Inflammatory Bowel Disease in the United StatesInflammatory Bowel Diseases 2016; 22(8): 2023 doi: 10.1097/MIB.0000000000000835
127
Anna Bellizzi, Valentina Barucca, Daniela Fioriti, Maria T. Colosimo, Monica Mischitelli, Elena Anzivino, Fernanda Chiarini, Valeria Pietropaolo. Early years of biological agents therapy in Crohn's disease and risk of the human polyomavirus JC reactivationJournal of Cellular Physiology 2010; 224(2): 316 doi: 10.1002/jcp.22146
128
Tanja Werner, Dirk Haller. Intestinal epithelial cell signalling and chronic inflammation: From the proteome to specific molecular mechanismsMutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2007; 622(1-2): 42 doi: 10.1016/j.mrfmmm.2007.05.010
129
Nabeetha A Nagalingam, Courtney J Robinson, Ingrid L Bergin, Kathryn A Eaton, Gary B Huffnagle, Vincent B Young. The effects of intestinal microbial community structure on disease manifestation in IL-10-/- mice infected with Helicobacter hepaticusMicrobiome 2013; 1(1) doi: 10.1186/2049-2618-1-15
130
Toshiaki Watanabe, Tsuyoshi Konishi, Junji Kishimoto, Kenjiro Kotake, Tetsuichiro Muto, Kenichi Sugihara. Ulcerative colitis-associated colorectal cancer shows a poorer survival than sporadic colorectal cancer: A nationwide Japanese studyInflammatory Bowel Diseases 2011; 17(3): 802 doi: 10.1002/ibd.21365
131
Edward J Ciaccio, Govind Bhagat, Suzanne K Lewis, Peter H Green. Trends in celiac disease researchComputers in Biology and Medicine 2015; 65: 369 doi: 10.1016/j.compbiomed.2015.05.023
132
HP Chu, V Logarajah, N Tan, KB Phua. Paediatric inflammatory bowel disease in a multiracial Asian countrySingapore Medical Journal 2013; : 201 doi: 10.11622/smedj.2013073
133
Amal J. Fatani, Khaled A. Al-Hosaini, Mohammed M. Ahmed, Hatem M. Abuohashish, Mihir Y. Parmar, Salim S. Al-Rejaie. Carvedilol Attenuates Inflammatory Biomarkers and Oxidative Stress in a Rat Model of Ulcerative ColitisDrug Development Research 2015; 76(4): 204 doi: 10.1002/ddr.21256
134
Ali Zargar, SomayehAhmadi Gooraji, Bahareh Keshavarzi, AliAkbar Haji Aghamohammadi. Effect of irritable bowel syndrome on sleep quality and quality of life of inflammatory bowel disease in clinical remissionInternational Journal of Preventive Medicine 2019; 10(1): 10 doi: 10.4103/ijpvm.IJPVM_364_17
135
Ha-Jeong Kim, Yan Zhang, Xiaojing Ma. Advances in the Management of Inflammatory Bowel Disease2013; : 6 doi: 10.2217/ebo.12.94
136
Axel Dignass, Rami Eliakim, Fernando Magro, Christian Maaser, Yehuda Chowers, Karel Geboes, Gerassimos Mantzaris, Walter Reinisch, Jean-Frederic Colombel, Severine Vermeire, Simon Travis, James O. Lindsay, Gert Van Assche. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosisJournal of Crohn's and Colitis 2012; 6(10): 965 doi: 10.1016/j.crohns.2012.09.003
137
Thomas Cars, Björn Wettermark, Robert Löfberg, Irene Eriksson, Johan Sundström, Mikael Lördal. Healthcare Utilisation and Drug Treatment in a Large Cohort of Patients with Inflammatory Bowel DiseaseJournal of Crohn's and Colitis 2016; 10(5): 556 doi: 10.1093/ecco-jcc/jjv243
138
Yi Li, Colin de Haar, Maikel P. Peppelenbosch, C. Janneke van der Woude. SOCS3 in immune regulation of inflammatory bowel disease and inflammatory bowel disease-related cancerCytokine & Growth Factor Reviews 2012; 23(3): 127 doi: 10.1016/j.cytogfr.2012.04.005
139
Xiaoping Wang, Yang Sun, Yue Zhao, Youxiang Ding, Xiaobo Zhang, Lingyi Kong, Zhiyu Li, Qinglong Guo, Li Zhao. Oroxyloside prevents dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB pathway through PPARγ activationBiochemical Pharmacology 2016; 106: 70 doi: 10.1016/j.bcp.2016.02.019
140
Rodney R. Dietert. Immunotoxicity, Immune Dysfunction, and Chronic DiseaseMolecular and Integrative Toxicology 2012; : 291 doi: 10.1007/978-1-61779-812-2_12
141
Clare M. Reynolds, Christine E. Loscher, Aidan P. Moloney, Helen M. Roche. Cis-9,trans-11-conjugated linoleic acid but not its precursortrans-vaccenic acid attenuate inflammatory markers in the human colonic epithelial cell line Caco-2British Journal of Nutrition 2008; 100(1): 13 doi: 10.1017/S0007114508894329
142
K. V. Shepitko. APPLICATION OF CRYOPRESERVED PLACENTA PREPARATIONS IN THE SMALL INTESTINE PATHOLOGIES IN RATS FOR THEIR FURTHER USE IN EXIGENT CONDITIONS Bulletin of Problems Biology and Medicine 2020; 4(2): 56 doi: 10.29254/2077-4214-2019-4-2-154-56-61
143
Tamas Szamosi, Peter Laszlo Lakatos, Aniko Szilvasi, Laszlo Lakatos, Agota Kovacs, Tamas Molnar, Istvan Altorjay, Maria Papp, Orsolya Szabo, Anna Satori, Zsolt Tulassay, Pal Miheller, Henrik Csaba Horvath, Janos Papp, Attila Tordai, Hajnalka Andrikovics. The 3′UTR NFKBIA Variant Is Associated with Extensive Colitis in Hungarian IBD PatientsDigestive Diseases and Sciences 2009; 54(2): 351 doi: 10.1007/s10620-008-0351-6
144
Agnès Baudet, Gabriel Rahmi, Anne-Laure Bretagne, Romain Gloro, Anne-Marie Justum, Jean-Marie Reimund. Severe ulcerative colitis: present medical treatment strategiesExpert Opinion on Pharmacotherapy 2008; 9(3): 447 doi: 10.1517/14656566.9.3.447
145
Julio Gálvez, Desiree Camuesco, Maria Elena Rodríguez-Cabezas, Antonio Zarzuelo. Olives and Olive Oil in Health and Disease Prevention2010; : 1049 doi: 10.1016/B978-0-12-374420-3.00113-3
146
Elisa Meroni, Nathalie Stakenborg, Pedro J. Gomez-Pinilla, Gert De Hertogh, Gera Goverse, Gianluca Matteoli, Simon Verheijden, Guy E. Boeckxstaens, Yvette Tache. Functional characterization of oxazolone-induced colitis and survival improvement by vagus nerve stimulationPLOS ONE 2018; 13(5): e0197487 doi: 10.1371/journal.pone.0197487
147
Cameron M Armstrong, Autumn R Billimek, Kimberly F Allred, Joseph M Sturino, Brad R Weeks, Clinton D Allred. A novel shift in estrogen receptor expression occurs as estradiol suppresses inflammation-associated colon tumor formationEndocrine-Related Cancer 2013; 20(4): 515 doi: 10.1530/ERC-12-0308
148
Melissa H. Roberts, Esther Erdei. Comparative United States autoimmune disease rates for 2010–2016 by sex, geographic region, and raceAutoimmunity Reviews 2020; 19(1): 102423 doi: 10.1016/j.autrev.2019.102423
149
Peter Laszlo Lakatos. Prevalence, predictors, and clinical consequences of medical adherence in IBD: How to improve it?World Journal of Gastroenterology 2009; 15(34): 4234-4239 doi: 10.3748/wjg.15.4234
150
Monzer Chehab, James Hlubocky, Elena Olariu, David Bloom, Kiran Nandalur. Comprehensive Magnetic Resonance Enterography of Crohn׳s Disease in the Pediatric Population: Technique, Interpretation, and ManagementCurrent Problems in Diagnostic Radiology 2015; 44(2): 193 doi: 10.1067/j.cpradiol.2014.07.003
151
S. Inamdar, A. Volfson, L. Rosen, S. Sunday, S. Katz, K. Sultan. Smoking and Early Infliximab Response in Crohn's Disease: a Meta-analysisJournal of Crohn's and Colitis 2015; 9(2): 140 doi: 10.1093/ecco-jcc/jju018
152
E. Volpato, C. Bosio, E. Previtali, S. Leone, A. Armuzzi, F. Pagnini, G. Graffigna. The evolution of IBD perceived engagement and care needs across the life-cycle: a scoping reviewBMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-01850-1
153
E. Joline de Groof, Noortje G.M. Rossen, Bram D. van Rhijn, Evert P.M. Karregat, Kirsten Boonstra, Ishtu Hageman, Floor Bennebroek Evertsz, Paul J. Kingma, Anton H.J. Naber, Jan H.M. van den Brande, Rosalie C. Mallant-Hent, Marco W. Mundt, Geert R.A.M. D’Haens, Cyriel Y. Ponsioen. Burden of disease and increasing prevalence of inflammatory bowel disease in a population-based cohort in the NetherlandsEuropean Journal of Gastroenterology & Hepatology 2016; 28(9): 1065 doi: 10.1097/MEG.0000000000000660
154
Mahyar Nourian, Vahid Chaleshi, Leila Pishkar, Pedram Azimzadeh, Shaghayegh Baradaran Ghavami, Hedieh Balaii, Samaneh Alinaghi, Shabnam Shahrokh, Hamid Asadzadeh Aghdaei, Mohammad Reza Zali. Evaluation of tumor necrosis factor (TNF)-α mRNA expression level and the rs1799964 polymorphism of the TNF-α gene in peripheral mononuclear cells of patients with inflammatory bowel diseasesBiomedical Reports 2017; 6(6): 698 doi: 10.3892/br.2017.908
155
Peter Laszlo Lakatos, Zsofia Czegledi, Tamas Szamosi, Janos Banai, Gyula David, Ferenc Zsigmond, Tunde Pandur, Zsuzsanna Erdelyi, Orsolya Gemela, Janos Papp, Laszlo Lakatos. Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behavior change in patients with Crohn’s diseaseWorld Journal of Gastroenterology 2009; 15(28): 3504-3510 doi: 10.3748/wjg.15.3504
156
Abdolmehdi Baghaei, MohammadHassan Emami, Peyman Adibi, Hamid Tavakkoli, Hamed Daghaghzadeh, Babak Tamizifar, MohammadJavad Akbarpour, Badri Hojjatpour. Inflammatory bowel disease registry and monitoring: Feasibility study and application (Isfahan Inflammatory Bowel Disease Surveillance Project)International Journal of Preventive Medicine 2019; 10(1): 190 doi: 10.4103/ijpvm.IJPVM_316_17
157
David Bauché, Barbara Joyce-Shaikh, Renu Jain, Jeff Grein, Karin S. Ku, Wendy M. Blumenschein, Stephanie C. Ganal-Vonarburg, Douglas C. Wilson, Terrill K. McClanahan, Rene de Waal Malefyt, Andrew J. Macpherson, Lakshmanan Annamalai, Jennifer H. Yearley, Daniel J. Cua. LAG3+ Regulatory T Cells Restrain Interleukin-23-Producing CX3CR1+ Gut-Resident Macrophages during Group 3 Innate Lymphoid Cell-Driven ColitisImmunity 2018; 49(2): 342 doi: 10.1016/j.immuni.2018.07.007
158
Yamilka Abreu-Delgado, Raymond A Isidro, Esther A Torres, Alexandra González, Myrella L Cruz, Angel A Isidro, Carmen I González-Keelan, Priscilla Medero, Caroline B Appleyard. Serum vitamin D and colonic vitamin D receptor in inflammatory bowel diseaseWorld Journal of Gastroenterology 2016; 22(13): 3581-3591 doi: 10.3748/wjg.v22.i13.3581
159
Geert D'Haens, William J Sandborn, Jean Frederic Colombel, Paul Rutgeerts, Kurt Brown, Hadas Barkay, Anat Sakov, Asi Haviv, Brian G Feagan. A phase II study of laquinimod in Crohn's diseaseGut 2015; 64(8): 1227 doi: 10.1136/gutjnl-2014-307118
160
Russell Cohen, Martha Skup, A. Burak Ozbay, Joanne Rizzo, Min Yang, Melissa Diener, Jingdong Chao. Direct and indirect healthcare resource utilization and costs associated with ulcerative colitis in a privately-insured employed population in the USJournal of Medical Economics 2015; 18(6): 447 doi: 10.3111/13696998.2015.1021353
161
Brenda Murphy, Dara Oliver Kavanagh, Desmond Colm Winter. Modern surgery for ulcerative colitisUpdates in Surgery 2020; 72(2): 325 doi: 10.1007/s13304-020-00719-4
162
Wallace Crandall, Michael D. Kappelman, Richard B. Colletti, Ian Leibowitz, John E. Grunow, Sabina Ali, Howard I. Baron, James H. Berman, Brendan Boyle, Stanley Cohen, Fernando del Rosario, Lee A. Denson, Lynn Duffy, Mark J. Integlia, Sandra C. Kim, David Milov, Ashish S. Patel, Bess T. Schoen, Dorota Walkiewicz, Peter Margolis. ImproveCareNow: The development of a pediatric inflammatory bowel disease improvement networkInflammatory Bowel Diseases 2011; 17(1): 450 doi: 10.1002/ibd.21394
163
Pedro Gonçalves, João Ricardo Araújo, James P Di Santo. A Cross-Talk Between Microbiota-Derived Short-Chain Fatty Acids and the Host Mucosal Immune System Regulates Intestinal Homeostasis and Inflammatory Bowel DiseaseInflammatory Bowel Diseases 2018; 24(3): 558 doi: 10.1093/ibd/izx029
164
Tanja Stenbaek Hansen, Tine Jess, Ida Vind, Margarita Elkjaer, Malene Fey Nielsen, Michael Gamborg, Pia Munkholm. Environmental factors in inflammatory bowel disease: A case-control study based on a Danish inception cohortJournal of Crohn's and Colitis 2011; 5(6): 577 doi: 10.1016/j.crohns.2011.05.010
165
Rogerio S Parra, Julio MF Chebli, Heda MBS Amarante, Cristina Flores, Jose ML Parente, Odery Ramos, Milene Fernandes, Jose JR Rocha, Marley R Feitosa, Omar Feres, Antonio S Scotton, Rodrigo B Nones, Murilo M Lima, Cyrla Zaltman, Carolina D Goncalves, Isabella M Guimaraes, Genoile O Santana, Ligia Y Sassaki, Rogerio S Hossne, Mauro Bafutto, Roberto LK Junior, Mikaell AG Faria, Sender J Miszputen, Tarcia NF Gomes, Wilson R Catapani, Anderson A Faria, Stella CS Souza, Rosana F Caratin, Juliana T Senra, Maria LA Ferrari. Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in BrazilWorld Journal of Gastroenterology 2019; 25(38): 5862-5882 doi: 10.3748/wjg.v25.i38.5862
166
Charalampia Amerikanou, Eirini Dimitropoulou, Aristea Gioxari, Efstathia Papada, Anthi Tanaini, Charalambos Fotakis, Panagiotis Zoumpoulakis, Andriana C. Kaliora. Linking the IL-17A immune response with NMR-based faecal metabolic profile in IBD patients treated with MastihaBiomedicine & Pharmacotherapy 2021; 138: 111535 doi: 10.1016/j.biopha.2021.111535
167
Rasmus Rankala, Juuso Kosonen, Kalle Mattila, Risto Tuominen, Markku Voutilainen, Anssi Mustonen. Direct costs of inflammatory bowel diseases in a Finnish tertiary-level clinicFrontline Gastroenterology 2021; 12(5): 385 doi: 10.1136/flgastro-2020-101466
168
Mariyana Schoultz, Leah Macaden, Gill Hubbard. Participants’ perspectives on mindfulness-based cognitive therapy for inflammatory bowel disease: a qualitative study nested within a pilot randomised controlled trialPilot and Feasibility Studies 2016; 2(1) doi: 10.1186/s40814-015-0041-z
169
Jan Seibel, Almut F. Molzberger, Torsten Hertrampf, Ute Laudenbach-Leschowski, Patrick Diel. Oral treatment with genistein reduces the expression of molecular and biochemical markers of inflammation in a rat model of chronic TNBS-induced colitisEuropean Journal of Nutrition 2009; 48(4): 213 doi: 10.1007/s00394-009-0004-3
170
Adam J. Hayek, Timothy P. Pfanner, Heath D. White. Inflammatory bowel disease of the lung: The role of infliximab?Respiratory Medicine Case Reports 2015; 15: 85 doi: 10.1016/j.rmcr.2015.05.012
171
Maria Papp, Istvan Altorjay, Gary L. Norman, Zakera Shums, Karoly Palatka, Zsuzsanna Vitalis, Ildiko Foldi, Gabriella Lakos, Judit Tumpek, Miklos L. Udvardy, Jolan Harsfalvi, Simon Fischer, Laszlo Lakatos, Agota Kovacs, Laszlo Bene, Tamas Molnar, Zsolt Tulassay, Pal Miheller, Gabor Veres, Janos Papp, Peter Laszlo Lakatos. Seroreactivity to microbial components in Crohnʼs disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patientsInflammatory Bowel Diseases 2007; 13(8): 984 doi: 10.1002/ibd.20146
172
D. Epstein. IBD 2007 — Achievements in Research and Clinical PracticeFalk Symposium 2008; 159: 45 doi: 10.1007/978-1-4020-6987-1_5
173
E.F. Stange, S.P.L. Travis, S. Vermeire, W. Reinisch, K. Geboes, A. Barakauskiene, R. Feakins, J.F. Fléjou, H. Herfarth, D.W. Hommes, L. Kupcinskas, P.L. Lakatos, G.J. Mantzaris, S. Schreiber, V. Villanacci, B.F. Warren. European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosisJournal of Crohn's and Colitis 2008; 2(1): 1 doi: 10.1016/j.crohns.2007.11.001
174
Eiichi Momotani, Ndanyi M. Romona, Kazuhiro Yoshihara, Yuriko Momotani, Masatoshi Hori, Hiroshi Ozaki, Shigetoshi Eda, Masahiro Ikegami. Molecular pathogenesis of bovine paratuberculosis and human inflammatory bowel diseasesVeterinary Immunology and Immunopathology 2012; 148(1-2): 55 doi: 10.1016/j.vetimm.2012.03.005
175
Toumi Ryma, Arezki Samer, Imene Soufli, Hayet Rafa, Chafia Touil-Boukoffa. Role of Probiotics and Their Metabolites in Inflammatory Bowel Diseases (IBDs)Gastroenterology Insights 2021; 12(1): 56 doi: 10.3390/gastroent12010006
176
Jacqueline Van De Walle, Béatrice Romier, Yvan Larondelle, Yves-Jacques Schneider. Influence of deoxynivalenol on NF-κB activation and IL-8 secretion in human intestinal Caco-2 cellsToxicology Letters 2008; 177(3): 205 doi: 10.1016/j.toxlet.2008.01.018
177
Josep Bassaganya-Riera, Raquel Hontecillas. Dietary conjugated linoleic acid and n-3 polyunsaturated fatty acids in inflammatory bowel diseaseCurrent Opinion in Clinical Nutrition and Metabolic Care 2010; 13(5): 569 doi: 10.1097/MCO.0b013e32833b648e
178
Chang Hwan Choi, Won Moon, You Sun Kim, Eun Soo Kim, Bo-In Lee, Yunho Jung, Yong Sik Yoon, Heeyoung Lee, Dong Il Park, Dong Soo Han. Second Korean Guideline for the Management of Ulcerative ColitisThe Korean Journal of Gastroenterology 2017; 69(1): 1 doi: 10.4166/kjg.2017.69.1.1
179
Nader Al-Shamma, Ali Jwaid. Exploring the potential in utilising smartphones to aid in the treatment and management of inflammatory bowel disease2016 Future Technologies Conference (FTC) 2016; : 696 doi: 10.1109/FTC.2016.7821680
180
M. L. Diouf, D. Dia, A. Thioubou, M. L. Bassène, M. Mbengue. Prévalence de la rectocolite hémorragique dans le centre d’endoscopie digestive de l’hôpital Aristide-Le-Dantec de DakarJournal Africain d'Hépato-Gastroentérologie 2010; 4(2): 97 doi: 10.1007/s12157-010-0158-x
181
Yi Gong, Hui Li, Yan Li. Effects of Bacillus subtilis on Epithelial Tight Junctions of Mice with Inflammatory Bowel DiseaseJournal of Interferon & Cytokine Research 2016; 36(2): 75 doi: 10.1089/jir.2015.0030
182
Amnon Sonnenberg. Demographic Characteristics of Hospitalized IBD PatientsDigestive Diseases and Sciences 2009; 54(11): 2449 doi: 10.1007/s10620-009-0973-3
183
Carol L. Roberts, Sarah L. Rushworth, Emile Richman, Jonathan M. Rhodes. Hypothesis: Increased consumption of emulsifiers as an explanation for the rising incidence of Crohn's diseaseJournal of Crohn's and Colitis 2013; 7(4): 338 doi: 10.1016/j.crohns.2013.01.004
184
Iqbal Siddique, Waleed Alazmi, Jaber Al-Ali, Joseph C. Longenecker, Ahmad Al-Fadli, Fuad Hasan, Anjum Memon. Demography and clinical course of ulcerative colitis in Arabs – a study based on the Montreal classificationScandinavian Journal of Gastroenterology 2014; 49(12): 1432 doi: 10.3109/00365521.2014.966318
185
Vibeke Andersen, Anja Olsen, Franck Carbonnel, Anne Tjønneland, Ulla Vogel. Diet and risk of inflammatory bowel diseaseDigestive and Liver Disease 2012; 44(3): 185 doi: 10.1016/j.dld.2011.10.001
186
C. X. W. Tan, H. S. Brand, N. K. H. de Boer, T. Forouzanfar. Gastrointestinal diseases and their oro-dental manifestations: Part 2: Ulcerative colitisBritish Dental Journal 2017; 222(1): 53 doi: 10.1038/sj.bdj.2017.37
187
S Keely, N J Talley, P M Hansbro. Pulmonary-intestinal cross-talk in mucosal inflammatory diseaseMucosal Immunology 2012; 5(1): 7 doi: 10.1038/mi.2011.55
188
Eva-Maria Collnot, Hussain Ali, Claus-Michael Lehr. Nano- and microparticulate drug carriers for targeting of the inflamed intestinal mucosaJournal of Controlled Release 2012; 161(2): 235 doi: 10.1016/j.jconrel.2012.01.028
189
Xiaofa Qin. What caused the extra high incidence of inflammatory bowel disease in the industrialized countries in the west: Lack of some nutrients or increased intake of some harmful agents?Inflammatory Bowel Diseases 2009; 15(2): 319 doi: 10.1002/ibd.20606
190
Lily P.H. Yang, Paul L. McCormack. MMX® MesalazineDrugs 2011; 71(2): 221 doi: 10.2165/11205870-000000000-00000
191
Seyed Alireza Taghavi, Ali Reza Safarpour, Seyed Vahid Hosseini, Hesam Noruzi, Maral Safarpour, Sala Rahimikazerooni. Epidemiology of Inflammatory Bowel Diseases (IBD) in Iran: A Review of 740 Patients in Fars Province, Southern IranAnnals of Colorectal Research 2013; 1(1) doi: 10.5812/acr.11477
192
P.L. Lakatos, T. Szamosi, A. Szilvasi, E. Molnar, L. Lakatos, A. Kovacs, T. Molnar, I. Altorjay, M. Papp, Z. Tulassay, P. Miheller, J. Papp, A. Tordai, H. Andrikovics. ATG16L1 and IL23 receptor (IL23R) genes are associated with disease susceptibility in Hungarian CD patientsDigestive and Liver Disease 2008; 40(11): 867 doi: 10.1016/j.dld.2008.03.022
193
Ramir Luan PERIN, Aderson Omar Mourão Cintra DAMIÃO, Cristina FLORES, Juliano Coelho LUDVIG, Daniéla Oliveira MAGRO, Eron Fábio MIRANDA, Antonio Carlos de MORAES, Rodrigo Bremer NONES, Fábio Vieira TEIXEIRA, Marco ZERONCIO, Paulo Gustavo KOTZE. VEDOLIZUMAB IN THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASES: A BRAZILIAN OBSERVATIONAL MULTICENTRIC STUDYArquivos de Gastroenterologia 2019; 56(3): 312 doi: 10.1590/s0004-2803.201900000-58
194
Jing Zhao, Min-Yi Cui, Tao Chan, Ren Mao, Yanji Luo, Indira Barua, Minhu Chen, Zi-Ping Li, Shi-Ting Feng. Evaluation of intestinal tuberculosis by multi-slice computed tomography enterographyBMC Infectious Diseases 2015; 15(1) doi: 10.1186/s12879-015-1325-x
195
Feodora I. Kostadinova, Tomohisa Baba, Yuko Ishida, Toshikazu Kondo, Boryana K. Popivanova, Naofumi Mukaida. Crucial involvement of the CX3CR1-CX3CL1 axis in dextran sulfate sodium-mediated acute colitis in miceJournal of Leukocyte Biology 2010; 88(1): 133 doi: 10.1189/jlb.1109768
196
Liesbeth Allais, Frederiek-Maarten Kerckhof, Stephanie Verschuere, Ken R. Bracke, Rebecca De Smet, Debby Laukens, Pieter Van den Abbeele, Martine De Vos, Nico Boon, Guy G. Brusselle, Claude A. Cuvelier, Tom Van de Wiele. Chronic cigarette smoke exposure induces microbial and inflammatory shifts and mucin changes in the murine gutEnvironmental Microbiology 2016; 18(5): 1352 doi: 10.1111/1462-2920.12934
197
A. G. Kharitonov, O. B. Shchukina, E. A. Kondrashina. Steroid resistance in inflammatory bowel diseaseAlmanac of Clinical Medicine 2016; 44(6): 734 doi: 10.18786/2072-0505-2016-44-6-734-743
198
Joseph JY Sung, Michael A Kamm, Philippe Marteau. Asian perspectives in the management of inflammatory bowel disease: Findings from a recent surveyJournal of Gastroenterology and Hepatology 2010; 25(1): 183 doi: 10.1111/j.1440-1746.2009.06024.x
199
H.M. Kuznietsova, E.O. Denis, T.Z. Moskalets, V.K. Rybalchenko. Effects of milk thistle and flaxseed oils obtained by the methods of cold and hot pressings on the state of colon under acute colitis in ratsReports of the National Academy of Sciences of Ukraine 2017; (3): 85 doi: 10.15407/dopovidi2017.03.085
200
P. L. Lakatos, I. Altorjay, Y. Mándi, L. Lakatos, J. Tumpek, A. Kovacs, T. Molnar, Z. Tulassay, P. Miheller, K. Palatka, T. Szamosi, S. Fischer, J. Papp, M. Papp. Interaction between seroreactivity to microbial antigens and genetics in Crohn’s disease: is there a role for defensins?Tissue Antigens 2008; 71(6): 552 doi: 10.1111/j.1399-0039.2008.01049.x
201
Yi Han, Mou-Bin Lin, Yong-Gang He, Hao-Bo Zhang, Ya-Jie Zhang, Lu Yin. Laparoscopic Surgery for Inflammatory Bowel Disease—The Experience in ChinaJournal of Investigative Surgery 2013; 26(4): 180 doi: 10.3109/08941939.2012.732664
202
Hongbo Zhang, Mohammed-Ali Shahbazi, Patrick V. Almeida, Hélder A. Santos. Mucosal Delivery of Biopharmaceuticals2014; : 59 doi: 10.1007/978-1-4614-9524-6_3
203
Daniel G. Fernández-Ávila, Santiago Bernal-Macías, Viviana Parra-Izquierdo, Diana N. Rincón-Riaño, Juan M. Gutiérrez, Diego Rosselli. Prevalencia en Colombia de la enfermedad inflamatoria intestinal y el compromiso articular asociado, según información del Sistema Integral de Información de la Protección SocialRevista Colombiana de Reumatología 2020; 27(1): 3 doi: 10.1016/j.rcreu.2019.10.006
204
D. EPSTEIN, G. WATERMEYER, R. KIRSCH. Review article: the diagnosis and management of Crohn’s disease in populations with high-risk rates for tuberculosisAlimentary Pharmacology & Therapeutics 2007; 25(12): 1373 doi: 10.1111/j.1365-2036.2007.03332.x
205
Aiga Staka, Edgars Bodnieks, Aldis Puķītis. Impact of Oat-Based Products on Human Gastrointestinal TractProceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences. 2015; 69(4): 145 doi: 10.1515/prolas-2015-0021
206
Steven R. Sloan, Chester Andrzejewski, Nicole A. Aqui, Joseph E. Kiss, Peter J. Krause, Yara A. Park. Role of therapeutic apheresis in infectious and inflammatory diseases: Current knowledge and unanswered questionsJournal of Clinical Apheresis 2015; 30(5): 259 doi: 10.1002/jca.21370
207
Eduard Cabré, Míriam Mañosa, Miquel A. Gassull. Omega-3 fatty acids and inflammatory bowel diseases – a systematic reviewBritish Journal of Nutrition 2012; 107(S2): S240 doi: 10.1017/S0007114512001626
208
Amnon Sonnenberg. Hospitalization for Inflammatory Bowel Disease in the United States Between 1970 and 2004Journal of Clinical Gastroenterology 2009; 43(4): 297 doi: 10.1097/MCG.0b013e31816244a0
209
Matteo Ruggeri, Francesca Romana Rolli. Cost per response/remission in biologics available in Italy for the treatment of TNF-α inhibitors-naïve patients with ulcerative colitisGlobal & Regional Health Technology Assessment: Italian; Northern Europe and Spanish 2019; 2019: 228424031882243 doi: 10.1177/2284240318822434
210
Shelley B. Weisser, Hayley K. Brugger, Nicole S. Voglmaier, Keith W. McLarren, Nico van Rooijen, Laura M. Sly. SHIP-deficient, alternatively activated macrophages protect mice during DSS-induced colitisJournal of Leukocyte Biology 2011; 90(3): 483 doi: 10.1189/jlb.0311124
211
Punithavathi Ranganathan, Calpurnia Jayakumar, Dean Y. Li, Ganesan Ramesh. UNC 5B receptor deletion exacerbates DSS ‐induced colitis in mice by increasing epithelial cell apoptosis Journal of Cellular and Molecular Medicine 2014; 18(7): 1290 doi: 10.1111/jcmm.12280
212
Pal Miheller, Lajos S Kiss, Mark Juhasz, Michael Mandel, Peter L Lakatos. Recommendations for identifying Crohn’s disease patients with poor prognosisExpert Review of Clinical Immunology 2013; 9(1): 65 doi: 10.1586/eci.12.86
213
Dania AlQasrawi, Latifa S. Abdelli, Saleh A. Naser. Mystery Solved: Why Smoke Extract Worsens Disease in Smokers with Crohn’s Disease and Not Ulcerative Colitis? Gut MAP!Microorganisms 2020; 8(5): 666 doi: 10.3390/microorganisms8050666
214
Eun Ji Lee, Tae Oh Kim, Geun Am Song, Jong hun Lee, Hyung Wook Kim, Sam Ryong Jee, Seun Ja Park, Hyun Jin Kim, Jong Ha Park. Clinical features of Crohn's disease in Korean patients residing in Busan and GyeongnamIntestinal Research 2016; 14(1): 30 doi: 10.5217/ir.2016.14.1.30
215
Zhaoxia Zhang, Chen Li, Xinmei Zhao, Chaolan Lv, Qiong He, Shan Lei, Yandong Guo, Fachao Zhi. Anti-Saccharomyces cerevisiae Antibodies Associate with Phenotypes and Higher Risk for Surgery in Crohn’s Disease: A Meta-AnalysisDigestive Diseases and Sciences 2012; 57(11): 2944 doi: 10.1007/s10620-012-2244-y
216
Ken S. Lau, Alwin M. Juchheim, Kimberly R. Cavaliere, Sarah R. Philips, Douglas A. Lauffenburger, Kevin M. Haigis. In Vivo Systems Analysis Identifies Spatial and Temporal Aspects of the Modulation of TNF-α–Induced Apoptosis and Proliferation by MAPKsScience Signaling 2011; 4(165) doi: 10.1126/scisignal.2001338
217
Colin B. Peirce, Matthew F. Kalady. Fundamentals of Anorectal Surgery2019; : 531 doi: 10.1007/978-3-319-65966-4_29
218
Vivian P. Hernandez-Trujillo, Chris Scalchunes, Charlotte Cunningham-Rundles, Hans D. Ochs, Francisco A. Bonilla, Ken Paris, Leman Yel, Kathleen E. Sullivan. Autoimmunity and Inflammation in X-linked AgammaglobulinemiaJournal of Clinical Immunology 2014; 34(6): 627 doi: 10.1007/s10875-014-0056-x
219
Oriana M Damas, Darius A Jahann, Robert Reznik, Jacob L McCauley, Leonardo Tamariz, Amar R Deshpande, Maria T Abreu, Daniel A Sussman. Phenotypic Manifestations of Inflammatory Bowel Disease Differ Between Hispanics and Non-Hispanic Whites: Results of a Large Cohort StudyAmerican Journal of Gastroenterology 2013; 108(2): 231 doi: 10.1038/ajg.2012.393
220
Xuan Huang, Bin Lv, Hai-feng Jin, Shuo Zhang. A meta-analysis of the therapeutic effects of tumor necrosis factor-α blockers on ulcerative colitisEuropean Journal of Clinical Pharmacology 2011; 67(8): 759 doi: 10.1007/s00228-011-1079-3
221
R. Goel, J. Hardman, M. Gulati, J. O'Donohue. Video Capsule Retention in Inflammatory Bowel Disease: An Unusual Presentation and Discussion of Retrieval MethodsCase Reports in Gastrointestinal Medicine 2013; 2013: 1 doi: 10.1155/2013/607142
222
Corrie Studd, Georgina Cameron, Lauren Beswick, Ross Knight, Christopher Hair, John McNeil, Paul Desmond, Jarrad Wilson, Wiliam Connell, Sally Bell. Never underestimate inflammatory bowel disease: High prevalence rates and confirmation of high incidence rates in AustraliaJournal of Gastroenterology and Hepatology 2016; 31(1): 81 doi: 10.1111/jgh.13050
223
Mariyana Schoultz, Iain Atherton, Gill Hubbard, Angus JM Watson. Assessment of causal link between psychological factors and symptom exacerbation in inflammatory bowel disease: a protocol for systematic review of prospective cohort studiesSystematic Reviews 2013; 2(1) doi: 10.1186/2046-4053-2-8
224
Bin Zheng, Jeroen van Bergenhenegouwen, Saskia Overbeek, Hendrik J. G. van de Kant, Johan Garssen, Gert Folkerts, Paul Vos, Mary E. Morgan, Aletta D. Kraneveld, Ivan J. Fuss. Bifidobacterium breve Attenuates Murine Dextran Sodium Sulfate-Induced Colitis and Increases Regulatory T Cell ResponsesPLoS ONE 2014; 9(5): e95441 doi: 10.1371/journal.pone.0095441
225
Luis Vida Pérez, Federico Gómez Camacho, Valle García Sánchez, Eva M.a Iglesias Flores, Laura Castillo Molina, Antonio Cerezo Ruiz, Luis Casáis Juanena, Juan Francisco De Dios Vega. Eficacia de la vacuna contra el virus de la hepatitis B en pacientes con enfermedad inflamatoria intestinalMedicina Clínica 2009; 132(9): 331 doi: 10.1016/j.medcli.2008.07.013
226
Chang Hwan Choi, Won Moon, You Sun Kim, Eun Soo Kim, Bo-In Lee, Yunho Jung, Yong Sik Yoon, Heeyoung Lee, Dong Il Park, Dong Soo Han. Second Korean guidelines for the management of ulcerative colitisIntestinal Research 2017; 15(1): 7 doi: 10.5217/ir.2017.15.1.7
227
Ke Ren, Hongjiang Yuan, Yijia Zhang, Xin Wei, Dong Wang. Macromolecular glucocorticoid prodrug improves the treatment of dextran sulfate sodium-induced mice ulcerative colitisClinical Immunology 2015; 160(1): 71 doi: 10.1016/j.clim.2015.03.027
228
Camille Aubry, Christophe Michon, Florian Chain, Yolande Chvatchenko, Laurence Goffin, Simone C. Zimmerli, Sylvia Leguin, Philippe Langella, Luis Bermudez-Humaran, Jean-Marc Chatel. Protective effect of TSLP delivered at the gut mucosa level by recombinant lactic acid bacteria in DSS-induced colitis mouse modelMicrobial Cell Factories 2015; 14(1) doi: 10.1186/s12934-015-0367-5
229
I.P. Kotlyar, H.M. Kuznіetsova, V.K. Rybalchenko. Biochemical effects of cold and hot-pressed thistle and linseed oils in rats with acute colitisNaukovì Dopovìdì Nacìonalʹnogo Unìversitetu Bìoresursiv ì Prirodokoristuvannâ Ukraïni 2021; (4(92)) doi: 10.31548/dopovidi2021.04.003
230
R. Dobie, V. E. MacRae, C. Pass, E. M. Milne, S. F. Ahmed, C. Farquharson. Suppressor of cytokine signaling 2 (SOCS2) deletion protects bone health of mice with DSS induced inflammatory bowel diseaseDisease Models & Mechanisms 2017;  doi: 10.1242/dmm.028456
231
Shanglei Liu, Samuel Eisenstein. State-of-the-art surgery for ulcerative colitisLangenbeck's Archives of Surgery 2021; 406(6): 1751 doi: 10.1007/s00423-021-02295-6
232
David Epstein, Chris Kassianides, Zeenat Gaibee, Gillian Watermeyer, Anne Griffiths. Inflammatory bowel disease in children in sub-Saharan AfricaPaediatrics and International Child Health 2020; 40(3): 141 doi: 10.1080/20469047.2020.1787020
233
A. Dignass, R. Eliakim, F. Magro, C. Maaser, Y. Chowers, K. Geboes, G. Mantzaris, W. Reinisch, J.-F. Colombel, S. Vermeire, S. Travis, J.O. Lindsay, G. van Assche. Segundo Consenso Europeo basado en evidencia sobre el diagnóstico y tratamiento de la colitis ulcerosa crónica idiopática Parte 1: Definiciones y diagnóstico (versión española)Revista de Gastroenterología de México 2014; 79(4): 263 doi: 10.1016/j.rgmx.2014.10.001
234
I.V. Byelinska, H.M. Kuznietsova, N.V. Dziubenko, O.V. Lynchak, T.V. Rybalchenko, Yu.I. Prylutskyy, O.A. Kyzyma, O. Ivankov, V.K. Rybalchenko, U. Ritter. Effect of С60 fullerenes on the intensity of colon damage and hematological signs of ulcerative colitis in ratsMaterials Science and Engineering: C 2018; 93: 505 doi: 10.1016/j.msec.2018.08.033
235
Konrad Aden, Wolfgang Reindl. The Gut Microbiome in Inflammatory Bowel Diseases: Diagnostic and Therapeutic ImplicationsVisceral Medicine 2019; 35(6): 332 doi: 10.1159/000504148
236
Yun-Na Song, Ping Zheng. Efficacy and safety of tumor necrosis factor-α blockers for ulcerative colitis: A systematic review and meta-analysis of published randomized controlled trialsJournal of Food and Drug Analysis 2015; 23(1): 1 doi: 10.1016/j.jfda.2014.06.003
237
Joseph E. Bornstein, Randolph M. Steinhagen. Crohn’s Disease2015; : 1 doi: 10.1007/978-3-319-14181-7_1
238
Jan Schwarz, Josef Sýkora, Dominika Cvalínová, Renáta Pomahačová, Jana Klečková, Martin Kryl, Petr Včelák. Inflammatory bowel disease incidence in Czech children: A regional prospective study, 2000-2015World Journal of Gastroenterology 2017; 23(22): 4090-4101 doi: 10.3748/wjg.v23.i22.4090
239
Martin Hauer-Jensen, James W. Denham, H. Jervoise N. Andreyev. Radiation enteropathy—pathogenesis, treatment and preventionNature Reviews Gastroenterology & Hepatology 2014; 11(8): 470 doi: 10.1038/nrgastro.2014.46
240
Maria Papp, Istvan Altorjay, Nir Dotan, Karoly Palatka, Ildiko Foldi, Judit Tumpek, Sandor Sipka, Miklos Udvardy, Tamas Dinya, Laszlo Lakatos, Agota Kovacs, Tamas Molnar, Zsolt Tulassay, Pal Miheller, Gary L. Norman, Tamas Szamosi, Janos Papp, Peter L. Lakatos. New Serological Markers for Inflammatory Bowel Disease Are Associated With Earlier Age at Onset, Complicated Disease Behavior, Risk for Surgery, and NOD2/CARD15 Genotype in a Hungarian IBD CohortThe American Journal of Gastroenterology 2008; 103(3): 665 doi: 10.1111/j.1572-0241.2007.01652.x
241
Meryem O. Pehlivaner Kara, Adam K. Ekenseair. In situspray deposition of cell-loaded, thermally and chemically gelling hydrogel coatings for tissue regenerationJournal of Biomedical Materials Research Part A 2016; 104(10): 2383 doi: 10.1002/jbm.a.35774
242
Ohad Atia, Sasha Harel, Shira Greenfeld, Natan Ledderman, Revital Kariv, Iris Dotan, Ran Balicer, Barbara Silverman, Eran Matz, Zohar Levi, Matti Waterman, Iris Fried, Jacob M. Rowe, Dan Turner. Risk of Cancer in Pediatric-Onset Inflammatory Bowel Diseases: A Nation-Wide Study from the Epi-IirnSSRN Electronic Journal 2021;  doi: 10.2139/ssrn.3777186
243
Min Lü, Bing Xia, Liuqing Ge, Yi Li, Jie Zhao, Fan Chen, Feng Zhou, Xiaolian Zhang, Jinquan Tan. Role of major histocompatibility complex class I-related molecules A*A5·1 allele in ulcerative colitis in Chinese patientsImmunology 2009; 128(1pt2): e230 doi: 10.1111/j.1365-2567.2008.02953.x
244
Peter Laszlo Lakatos. Use of new once-daily 5-aminosalicylic acid preparations in the treatment of ulcerative colitis: Is there anything new under the sun?World Journal of Gastroenterology 2009; 15(15): 1799-1804 doi: 10.3748/wjg.15.1799
245
Scott M. Hayter, Matthew C. Cook. Updated assessment of the prevalence, spectrum and case definition of autoimmune diseaseAutoimmunity Reviews 2012; 11(10): 754 doi: 10.1016/j.autrev.2012.02.001
246
Jot Hui Ooi, Amanda Waddell, Yang-Ding Lin, Istvan Albert, Laura T. Rust, Victoria Holden, Margherita T. Cantorna, Susan Kovats. Dominant Effects of the Diet on the Microbiome and the Local and Systemic Immune Response in MicePLoS ONE 2014; 9(1): e86366 doi: 10.1371/journal.pone.0086366
247
Chang Hwan Choi, Young-Ho Kim, You Sun Kim, Byong Duk Ye, Kang Moon Lee, Bo In Lee, Sung-Ae Jung, Won Ho Kim, Heeyoung Lee. Guidelines for the Management of Ulcerative ColitisIntestinal Research 2012; 10(1): 1 doi: 10.5217/ir.2012.10.1.1
248
James C. Lee, Paul A. Lyons, Eoin F. McKinney, John M. Sowerby, Edward J. Carr, Francesca Bredin, Hannah M. Rickman, Huzefa Ratlamwala, Alexander Hatton, Tim F. Rayner, Miles Parkes, Kenneth G.C. Smith. Gene expression profiling of CD8+ T cells predicts prognosis in patients with Crohn disease and ulcerative colitisJournal of Clinical Investigation 2011; 121(10): 4170 doi: 10.1172/JCI59255
249
Mark L. Heiman, Frank L. Greenway. A healthy gastrointestinal microbiome is dependent on dietary diversityMolecular Metabolism 2016; 5(5): 317 doi: 10.1016/j.molmet.2016.02.005
250
Felipe Bellolio Roth, Javier Gómez, Jaime Cerda. Increase in Hospital Discharges for Inflammatory Bowel Diseases in Chile Between 2001 and 2012Digestive Diseases and Sciences 2017; 62(9): 2311 doi: 10.1007/s10620-017-4660-5
251
Aristea Gioxari, Andriana C. Kaliora, Apostolos Papalois, George Agrogiannis, John K. Triantafillidis, Nikolaos K. Andrikopoulos. Pistacia lentiscus Resin Regulates Intestinal Damage and Inflammation in Trinitrobenzene Sulfonic Acid–Induced ColitisJournal of Medicinal Food 2011; 14(11): 1403 doi: 10.1089/jmf.2010.0240
252
Katharina Forster, Ashleigh Goethel, Catherine Wing–Tak Chan, Galliano Zanello, Catherine Streutker, Kenneth Croitoru. An Oral CD3-Specific Antibody Suppresses T-Cell–Induced Colitis and Alters Cytokine Responses to T-Cell Activation in MiceGastroenterology 2012; 143(5): 1298 doi: 10.1053/j.gastro.2012.07.019
253
Peter Laszlo Lakatos, Laszlo Lakatos. Ulcerative proctitis: a review of pharmacotherapy and managementExpert Opinion on Pharmacotherapy 2008; 9(5): 741 doi: 10.1517/14656566.9.5.741
254
Roland Hustinx, Edouard Louis. The Role of PET/CT in the Monitoring and Diagnosis of Pediatric Inflammatory Bowel DiseasePET Clinics 2008; 3(4): 597 doi: 10.1016/j.cpet.2009.04.003
255
Bin Zheng, Mary E. Morgan, Hendrik J.G. van de Kant, Johan Garssen, Gert Folkerts, Aletta D. Kraneveld. Transcriptional modulation of pattern recognition receptors in acute colitis in miceBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2013; 1832(12): 2162 doi: 10.1016/j.bbadis.2013.07.004
256
Z. Vegh, J. Burisch, N. Pedersen, I. Kaimakliotis, D. Duricova, M. Bortlik, S. Avnstrøm, K. Kofod Vinding, J. Olsen, K.R. Nielsen, K.H. Katsanos, E.V. Tsianos, L. Lakatos, D. Schwartz, S. Odes, G. Lupinacci, A. De Padova, L. Jonaitis, L. Kupcinskas, S. Turcan, O. Tighineanu, I. Mihu, L.F. Barros, F. Magro, D. Lazar, A. Goldis, A. Fernandez, V. Hernandez, O. Niewiadomski, S. Bell, E. Langholz, P. Munkholm, P.L. Lakatos. Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: Results of the 2011 ECCO-EpiCom inception cohortJournal of Crohn's and Colitis 2014; 8(11): 1506 doi: 10.1016/j.crohns.2014.06.004
257
Alex Olia, Chikako Shimokawa, Takashi Imai, Kazutomo Suzue, Hajime Hisaeda. Suppression of systemic lupus erythematosus in NZBWF1 mice infected with Hymenolepis microstomaParasitology International 2020; 76: 102057 doi: 10.1016/j.parint.2020.102057
258
Chris Green, Charles N. Bernstein. Lessons from geographic mapping of IBD in FranceInflammatory Bowel Diseases 2010; 16(5): 804 doi: 10.1002/ibd.21115
259
Fergus Shanahan, Charles N Bernstein. The evolving epidemiology of inflammatory bowel diseaseCurrent Opinion in Gastroenterology 2009; 25(4): 301 doi: 10.1097/MOG.0b013e32832b12ef
260
Ahn Sang Hyun, Kim Ki Bong. The anti-oxidative and anti-inflammatory effect of on Ulcerative Colitis Induced by Dextran Sulfate Sodium in MiceJournal of Korean Medicine 2016; 37(4): 10 doi: 10.13048/jkm.16043
261
Monica Viladomiu, Raquel Hontecillas, Josep Bassaganya-Riera. Modulation of inflammation and immunity by dietary conjugated linoleic acidEuropean Journal of Pharmacology 2016; 785: 87 doi: 10.1016/j.ejphar.2015.03.095
262
E. Papada, A. C. Kaliora, A. Gioxari, A. Papalois, A. Forbes. Anti-inflammatory effect of elemental diets with different fat composition in experimental colitisBritish Journal of Nutrition 2014; 111(7): 1213 doi: 10.1017/S0007114513003632
263
Masahiro Iizuka, Taku Harada, Hiro-o Yamano, Takeshi Etou, Shiho Sagara. Typical gastroduodenal endoscopic findings in a Crohn's disease patient in remission stageWorld Journal of Gastrointestinal Endoscopy 2012; 4(3): 96-98 doi: 10.4253/wjge.v4.i3.96
264
Karel Geboes. Morson and Dawson's Gastrointestinal Pathology2012; : 315 doi: 10.1002/9781118399668.ch20
265
Bruno César da Silva, Andre Castro Lyra, Raquel Rocha, Genoile Oliveira Santana. Epidemiology, demographic characteristics and prognostic predictors of ulcerative colitisWorld Journal of Gastroenterology 2014; 20(28): 9458-9467 doi: 10.3748/wjg.v20.i28.9458
266
Kelvin T. Thia, Edward V. Loftus, Jr, William J. Sandborn, Suk-Kyun Yang. An Update on the Epidemiology of Inflammatory Bowel Disease in AsiaThe American Journal of Gastroenterology 2008; 103(12): 3167 doi: 10.1111/j.1572-0241.2008.02158.x
267
Péter László Lakatos, László Lakatos. Effectiveness of new, once-daily 5-aminosalicylic acid in the treatment of ulcerative colitisOrvosi Hetilap 2009; 150(9): 397 doi: 10.1556/oh.2009.28555
268
D. Ortuño Sahagún, A. L. Márquez-Aguirre, S. Quintero-Fabián, R. I. López-Roa, A. E. Rojas-Mayorquín. Modulation of PPAR-γby Nutraceutics as Complementary Treatment for Obesity-Related Disorders and Inflammatory DiseasesPPAR Research 2012; 2012: 1 doi: 10.1155/2012/318613
269
Krisztina B Gecse, Peter L Lakatos. Ulcerative proctitis: an update on the pharmacotherapy and managementExpert Opinion on Pharmacotherapy 2014; 15(11): 1565 doi: 10.1517/14656566.2014.920322
270
Shapur Ikhtaire, Mohammad Sharif Shajib, Walter Reinisch, Waliul Islam Khan. Fecal calprotectin: its scope and utility in the management of inflammatory bowel diseaseJournal of Gastroenterology 2016; 51(5): 434 doi: 10.1007/s00535-016-1182-4
271
Stefan Schreiber, Michael A Kamm, Gary R Lichtenstein. Mesalamine with MMX™ technology for the treatment of ulcerative colitisExpert Review of Gastroenterology & Hepatology 2008; 2(3): 299 doi: 10.1586/17474124.2.3.299
272
Shlomo Birkenfeld, Ibrahim Zvidi, Rachel Hazazi, Yaron Niv. The Prevalence of Ulcerative Colitis in IsraelJournal of Clinical Gastroenterology 2009; 43(8): 743 doi: 10.1097/MCG.0b013e31818b3a02
273
Peter Laszlo Lakatos, Lajos S. Kiss, Pal Miheller. Nutritional Influences in Selected Gastrointestinal DiseasesDigestive Diseases 2011; 29(2): 154 doi: 10.1159/000323878
274
A S Parmar, M Lappalainen, P Paavola-Sakki, L Halme, M Färkkilä, U Turunen, K Kontula, A Aromaa, V Salomaa, L Peltonen, J Halfvarson, L Törkvist, M D'Amato, P Saavalainen, E Einarsdottir. Association of celiac disease genes with inflammatory bowel disease in Finnish and Swedish patientsGenes & Immunity 2012; 13(6): 474 doi: 10.1038/gene.2012.21
275
Peter Laszlo Lakatos, Istvan Altorjay, Tamas Szamosi, Karoly Palatka, Zsuzsanna Vitalis, Judit Tumpek, Sandor Sipka, Miklos Udvardy, Tamas Dinya, Laszlo Lakatos, Agota Kovacs, Tamas Molnar, Zsolt Tulassay, Pal Miheller, Zsolt Barta, Winfried Stocker, Janos Papp, Gabor Veres, Maria Papp. Pancreatic Autoantibodies Are Associated with Reactivity to Microbial Antibodies, Penetrating Disease Behavior, Perianal Disease, and Extraintestinal Manifestations, But Not with NOD2/CARD15 or TLR4 Genotype in a Hungarian IBD CohortInflammatory Bowel Diseases 2009; 15(3): 365 doi: 10.1002/ibd.20778
276
J. R. Goodhand, N. Kamperidis, N. M. Joshi, M. Wahed, Y. Koodun, E. J. Cantor, N. M. Croft, F. L. Langmead, J. O. Lindsay, D. S. Rampton. The phenotype and course of inflammatory bowel disease in UK patients of Bangladeshi descentAlimentary Pharmacology & Therapeutics 2012; 35(8): 929 doi: 10.1111/j.1365-2036.2012.05043.x
277
Xiao-hua Ling, Xin Yu, De-jun Kong, Cheng-yi Hu, Yu Hong, Xiao-ming Yang. Treatment of inflammatory bowel disease with Chinese drugs administered by both oral intake and retention enemaChinese Journal of Integrative Medicine 2010; 16(3): 222 doi: 10.1007/s11655-010-0222-0
278
Halyna M. Kuznietsova, Maryna S. Yena, Iryna P. Kotlyar, Olexandr V. Ogloblya, Volodymyr K. Rybalchenko. Anti-Inflammatory Effects of Protein Kinase Inhibitor Pyrrol DerivateThe Scientific World Journal 2016; 2016: 1 doi: 10.1155/2016/2145753